| Financial Year |
March 31 2023 |
| Monetary Funds |
6,891,253,571.86 |
| Held-for-trading Financial Assets |
405,705,674.59 |
| Notes Receivable |
-- |
| Accounts Receivable |
29,029,349.84 |
| Advances to Suppliers |
25,973,934.66 |
| Other Receivables |
5,096,860.93 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,789,826,369.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,671,198.92 |
| Total Current Assets |
9,183,556,960.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
17,869,624.82 |
| Fixed Assetes |
2,624,538,874.78 |
| Under-construction Projects |
533,365,467.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,363,070,971.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
356,622,848.17 |
| Other Non-Current Assets |
22,595,906.54 |
| Sub-Total of Non-Current Assets |
5,078,653,124.68 |
| Total Assets |
14,262,210,084.73 |
| Short-Term Loans |
1,296,176,469.48 |
| Trading Financial liabilities |
-- |
| Notes Payable |
66,853,993.18 |
| Accounts Payable |
449,365,113.44 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
102,686,178.96 |
| Taxes Payable |
111,556,227.73 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
437,524,465.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
502,647,187.14 |
| Other Current Liabilities |
6,709,133.51 |
| Sub-Total of Current Liabilities |
3,547,411,394.86 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
25,518,773.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
953,634,689.99 |
| Total Liabilities |
4,501,046,084.85 |
| Paid-In Capital(Or Share Stock) |
2,213,328,480.00 |
| Capital Surplus |
4,504,528,968.93 |
| Surplus Reserve |
252,558,510.98 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,730,911,806.09 |
| Minority Stockholder's Interest |
56,757,323.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,704,406,676.02 |
| Owner's Equity（Stockholder's Equity） |
9,761,163,999.88 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,262,210,084.73 |
